Government study strengthens case for giving 4th shot to immunocompromised — report

Children aged 5-11 receive their first dose of COVID-19 vaccine, at a vaccination center in Safed, northern Israel, December 3, 2021. (David Cohen/Flash90)
Children aged 5-11 receive their first dose of COVID-19 vaccine, at a vaccination center in Safed, northern Israel, December 3, 2021. (David Cohen/Flash90)

A government-commissioned study shows that immunocompromised people have responded well to the third coronavirus vaccine, strengthening the case for giving them a fourth shot, Ynet news reports.

The research by Prof. Galia Rahav, which examined the effectiveness of the booster in immunocompromised people three months after receiving it, shows that both bone marrow and heart transplant recipients respond well to the third dose, the report says.

The study reportedly examined the amount of neutralizing antibodies among 78 kidney transplant recipients, about 120 bone marrow transplant recipients and about 100 heart transplant recipients.

The decision regarding administering the fourth vaccine, which will be based on the research, is set to be made after data has been collected six months following receiving the third shot.

Most Popular
If you’d like to comment, join
The Times of Israel Community.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.